M I H I R P E N D S E & L O R A V. H O O P E R
B abies emerge from the womb into a world brimming with microbial life. Mammalian young inhabit a microbiologically sterile environment during fetal development, but are exposed to microbes from the moment of birth. The newborn intestine subsequently becomes colonized with trillions of microorganisms that promote digestion, block invading organisms and synthesize certain vitamins. How does the immature newborn immune system deal with this microbial onslaught? Writing in Science, Gomez de Agüero et al. 1 show that the bacteria that live in a pregnant mother's intestine provide signals that promote the development of her newborn's immune system, readying it to cope with large numbers of microbes.
Microbial colonization during the first days and weeks of newborn life has profound effects on immune-system development 2 . Many of these effects have been teased out by studies in germ-free mice, which are reared in a completely sterile setting. Germ-free mice exhibit numerous immune-system deficiencies, such as a dearth of the B and T cells that respond to foreign invaders 2 . But what happens before birth? Although the fetus lacks its own resident microorganisms, might the mother's own microbes provide cues that guide immunesystem development in her offspring?
Gomez de Agüero et al. addressed this question using a clever experimental trick in which they exposed germ-free mice to bacteria only during pregnancy. They chose a normal bacterial resident of the gut, Escherichia coli, but genetically hobbled it so that it wouldn't persist in the intestine for more than a few days 3 . Pregnant mice became colonized with the hobbled strain (called E. coli HA107) but then returned to a germ-free state before giving birth. Thus, the developing offspring were exposed to bacteria and their products only during pregnancy -not after birth.
The authors then studied the immune systems of offspring born to the transiently colonized mice. The newborns had increased numbers of two key immune cells that circulate throughout intestinal tissues and help to fight foreign invaders: group 3 innate lymphoid cells (ILC3s) 4 and intestinal mononuclear cells (iMNCs) 5 . Both cells are agents of the innate immune system, which is tasked with unleashing a rapid but nonspecific response to infection. Interestingly, ILC3 numbers remained elevated for several weeks after birth, suggesting that even transient colonization during pregnancy has long-term consequences for the offspring's immune system.
Although intestinal B-and T-cell numbers are boosted by colonizing germ-free mice after birth, these cells were unaffected by pregnancy-specific colonization of the germfree mice. B and T cells are agents of the adaptive immune system, which confers long-term, specific immunity to microorganisms. Thus, pregnancy-specific colonization seems to preferentially affect cells of the innate immune system, whereas cells of the adaptive immune system are shaped largely by microbial exposure after birth.
Gomez de Agüero et al. found that pregnancy-specific colonization also elevates the expression of large swathes of genes in the newborn intestine. These include genes involved in metabolism, oxidative stress and innate immunity. For example, there was increased expression of the gene encoding RegIIIγ, a secreted protein that minimizes bacterial attachment to the intestinal surface 6 . These findings suggest that maternal microbes trigger a wide range of intestinal adaptations that go beyond the changes in immune-cell numbers.
How do maternal gut microbes signal to the fetus to prime development of the innate immune system? The authors first ruled out direct exposure of the fetus to live bacteria as a possible mechanism. But when they transferred serum from a mother colonized with E. coli HA107 into a germ-free mother, the offspring born to the serum-transplanted mice displayed the same boost in ILC3 numbers and RegIIIγ expression. Interestingly, this boost depended partly on the mother's antibodies -circulating immune molecules that bind tightly to specific antigen molecules, including those derived from bacteria. Bacterial compounds from the mother were indeed present in newborn tissues, and maternal antibodies enhanced transfer of the compounds to the offspring. It is still not clear whether this antibody-facilitated transfer is due to direct antibody binding to microbial compounds. But these findings suggest that maternal antibodies bind to microbial molecules, enter the circulation and deliver the molecules to the 
Mum's microbes boost baby's immunity
The microorganisms that colonize pregnant mice have been shown to prime the innate immune system in newborn offspring, preparing them for life in association with microbes. 1 show that the presence of bacteria in the intestines of pregnant mice increases innate immunity in the offspring, and that this effect depends partly on the mother's circulating antibodies. Through an unclear mechanism, the antibodies promote transfer of microbial compounds to the developing fetus. This results in increased numbers of group 3 innate lymphoid cells (ILC3s) and increased expression of the RegIIIγ gene, which encodes the antimicrobial protein RegIIIγ, made by the intestinal epithelial lining. Numbers of intestinal mononuclear cells (iMNCs) are also boosted by pregnancy-specific colonization, but this increase is independent of the mother's antibodies.
developing fetus, where they prime immunesystem development (Fig. 1) .
When the authors investigated the chemical composition of the immunity-stimulating compounds, several were known binding partners of the aryl hydrocarbon receptor (AhR), which is essential for the development of key intestinal immune cells, including ILC3s 7 . Thus, AhR might be part of the mechanism by which maternal bacterial compounds are received by the offspring's immune system. Do maternal microbes confer any advantages to newborns in dealing with microbial exposures? When Gomez de Agüero et al. exposed newborns to intestinal bacteria, those born to pregnancy-colonized mothers were better able to limit the numbers of bacteria that penetrated to deeper tissues than were those born to germ-free mothers. This suggests that the immunity boost from the mother's microbes helps to protect neonates against the pathogenic effects of bacteria, and prepares the offspring for association with large microbial communities after birth.
There are several fascinating questions that remain to be addressed. Are there other receptors besides AhR that receive maternal microbial signals in the newborn immune system? Do maternal microbial communities associated with the skin and airways also prime newborn immunity? And do maternal intestinal bacteria affect immunity in any other organs of the newborn?
A major goal in studying gut bacteria is to use their beneficial properties to improve human health. 
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Ubiquitination without E1 and E2 enzymes
A protein in the pathogenic bacterium Legionella pneumophila has been found to attach the modifying molecule ubiquitin to human proteins, using a mechanism that, surprisingly, does not involve cellular E1 and E2 enzymes. See Letter p.120
biquitin is a polypeptide of 76 amino acids that, when covalently attached to substrate proteins, results in either modulation of the protein's function or its destruction by the cell's proteasome machinery. Since its discovery in the late 1970s, conjugation of ubiquitin to substrate proteins has been shown to have an essential role in controlling almost all cellular processes, including cell division, DNA repair and protein sy nthesis 1 . The mechanism of ubiquitination is universally conserved from yeast to humans and typically proceeds through a three-enzyme cascade. Yet in this issue, Qiu et al. 2 (page 120) report that the bacterial protein SdeA ubiquitinates several human Rab proteins without engaging any of this cellular ubiquitination machinery.
During standard cellular ubiquitination (Fig. 1a) , the ubiquitin-activating enzyme (E1) activates the carboxy terminus of ubiquitin in a process that costs one ATP molecule (the cellular energy 'currency'). The activated ubiquitin is then transferred from E1 to the ubiquitin-conjugating enzyme (E2). Finally, the ubiquitin ligase enzyme (E3) catalyses the transfer of ubiquitin from E2 to lysine amino-acid residues in the substrate protein, with or without an intermediary step of E3 self-modification 3, 4 . Bacteria do not possess this ubiquitination system, but some pathogenic bacteria have evolved toxic proteins (effectors) that resemble members of the system, which they use to modulate host-cell processes to facilitate their intracellular survival and multiplication 5 . The pathogenic bacterium Legionella pneumophila uses about 10% of its genome (about 300 genes) to encode effectors that help it to divide and evade host-defence mechanisms The E1 enzyme first activates the carboxy terminus of the ubiquitin molecule, using the energy from converting an ATP molecule to AMP and pyrophosphate (PP i ). The activated ubiquitin is attached to the sulfur of the E1 active-site cysteine residue. Ubiquitin is then transferred from E1 to E2, and E3 facilitates the transfer of ubiquitin from E2 to the substrate protein. b, Qiu et al. 2 report that the SdeA enzyme of Legionella pneumophila bacteria catalyses ubiquitination of the human protein Rab33 in a manner that is independent of E1 and E2. SdeA uses the cofactor NAD to add an ADP-ribose moiety to the arginine-42 (Arg 42 ) residue of ubiquitin in a reaction that releases nicotinamide. This is followed by modification(s) of the ADP-ribosylated ubiquitin that eventually leads to the ubiquitination of Rab33 and release of AMP, but the details of the chemistry of this transfer are not yet clear.
